Product Information
GS PAIN RELIEF 325 MG TABLET is a generic product labeled by L. Perrigo Company, priced at $0.0233 per EA under NDC 00113040378. Its NADAC has been published 348 times since Nov 28, 2013.
Strength
325 mg/1
Manufacturer
L. Perrigo CompanyNDC
00113040378
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
8/15/1989
Price Statistics
The NADAC for GS PAIN RELIEF 325 MG TABLET has been published 348 times since Nov 28, 2013, and over the history we have for it it has risen 110.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0233 per EA |
|---|---|
| All-time high | $0.0267 (Nov 13, 2024) |
| All-time low | $0.0105 (Dec 18, 2013) |
| 52-week high | $0.0267 |
| 52-week low | $0.0233 |
| Median price | $0.0238 |
| Average price | $0.0227 |
| Largest weekly change | +83.0% (Jun 10, 2020) |
| Weeks tracked | 348 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GS PAIN RELIEF 325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GS PAIN RELIEF 325 MG TABLET, manufactured by L. Perrigo Company, is $0.0233 per EA (NDC 00113040378), effective Sep 30, 2026.
How has the price of GS PAIN RELIEF 325 MG TABLET changed over time?
Over the history we have for it, the NADAC for GS PAIN RELIEF 325 MG TABLET has risen 110.4%. It has been tracked across 348 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GS PAIN RELIEF 325 MG TABLET?
Since Nov 28, 2013, the NADAC for GS PAIN RELIEF 325 MG TABLET has ranged from a low of $0.0105 (Dec 18, 2013) to a high of $0.0267 (Nov 13, 2024), with a median of $0.0238 per EA.
Are there cheaper alternatives to GS PAIN RELIEF 325 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC PAIN RELIEF 325 MG TABLET, is $0.0232 per EA — about 1% below GS PAIN RELIEF 325 MG TABLET.
Who manufactures GS PAIN RELIEF 325 MG TABLET?
GS PAIN RELIEF 325 MG TABLET (NDC 00113040378) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.